TKI grant recipients 2022
In 2022 several researchers of Amsterdam UMC have been awarded a TKI-PPP grant between € 300.000 and € 750.000 to perform a research project in collaboration with an industrial party.
The following videos highlight the 2022 grant recipients of the Amsterdam UMC TKI-PPP grant. For a quick overview of all the winners and their projects take a look at the intro below.
Projects of the 2022 grant recipients
About the TKI-PPI grant
In September 2021 the call for the Amsterdam UMC TKI grant 2021-2022 opened. The Amsterdam UMC TKI grants for PPP projects are available to all Amsterdam UMC researchers and aims to them to perform more research projects in collaboration with companies in Public-Private Partnerships (PPP).
The funding is provided by the NL government (Ministry of Economic Affairs) through the Rijksdienst voor Ondernemend Nederland (RVO) and the Topconsortium voor Kennis en Innovatie Life Sciences & Health (TKI-LSH, a.k.a. Health-Holland).
Biotech boost(er) for life sciences innovations
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News
PULSE Sport Wins Prestigious Dutch Sports Innovation Award 2024
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News
Start-up VU-AMS has big plans with clever stress monitoring device
VU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News